Compounds of the formula (I): ##STR00001## in which R, R.sup.1, R.sup.2 and R.sup.3 are as defined in the description, to their use for the treatment of dyslipidaemia, atherosclerosis and diabetes, to pharmaceutical compositions comprising them and to the processes for the preparation of these compounds.